ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wills, M.
Right arrow Articles by Herman, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wills, M.
Right arrow Articles by Herman, M.
Annals of Clinical and Laboratory Science, Vol 23, Issue 1, 1-16
Copyright © 1993 by Association of Clinical Scientists


Articles

Long-term oral or intravenous aluminum administration in rabbits. I. Renal and hepatic changes

MR Wills, CD Hewitt, BC Sturgill, J Savory, and MM Herman

Long-term aluminum (Al) administration was studied in rabbits using intravenous (I.V.) injections of aluminum maltol or oral aluminum citrate in drinking water along with calcium. In the intravenous study, renal and liver tissue Al levels increased and were associated with proximal renal tubular pathology and with hepatic periportal Al-positive multinucleated cells. After oral Al, renal Al levels were increased in the Al-hard water group, while hepatic Al levels were not significantly increased over controls. However, cirrhosis was found in five orally-loaded animals which received Al and/or low dietary calcium or soft water. Collectively, these findings suggest that renal accumulation of Al is causally related to nephrotoxicity; that the lack of renal changes after oral loading is due to low absorption from normal adult gastrointestinal tract and normal functioning of mature kidneys; and that the elevated liver Al levels, achieved after I.V. administration, are related to the presence of hepatic Al-containing giant cells.


This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
R. A. Yokel, K. A. Meurer, C. B. Hong, K. M. Dickey, T. L. Skinner, and A. M. Fredenburg
Short-Term Oral 3-Hydroxypyridin-4-one Dosing Increases Aluminum Excretion and Partially Reverses Aluminum-Induced Toxicity in the Rabbit Independent of Chelator Lipophilicity
Drug Metab. Dispos., February 1, 1997; 25(2): 182 - 190.
[Abstract] [Full Text]


Home page
Hum Exp ToxicolHome page
A. Spencer, J. Wood, H. Saunders, M. Freeman, and C. Lote
Aluminium deposition in liver and kidney following acute intravenous administration of aluminium chloride or citrate in conscious rats
Human and Experimental Toxicology, October 1, 1995; 14(10): 787 - 794.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the Association of Clinical Scientists.